Related Experiment Video

Updated: Sep 30, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Testis-specific HMG-domain protein alters the responses of cells to cisplatin

Deborah B Zamble1, Yuji Mikata, Christina H Eng

  • 1Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139-4307, USA.

Journal of Inorganic Biochemistry
|August 15, 2002
PubMed

Insights

Testicular cancer cells show reduced DNA repair for cisplatin damage, linked to a testis-specific protein (tsHMG). This protein enhances cisplatin

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Cisplatin is a key chemotherapy drug for testicular cancer.
  • Testicular cancer cells exhibit unique responses to cisplatin treatment.
  • Nucleotide excision repair (NER) is crucial for DNA damage repair.

Purpose of the Study:

  • To investigate the role of HMG-domain proteins in cisplatin resistance in testicular cells.
  • To determine if testis-specific HMG (tsHMG) influences DNA repair and cisplatin cytotoxicity.
  • To explore the mechanism by which tsHMG affects cellular response to cisplatin.

Main Methods:

  • Assessing DNA repair efficiency of cisplatin adducts in mouse testicular teratocarcinoma cell extracts.
  • Developing a HeLa cell line with inducible expression of tsHMG.
  • Analyzing cisplatin-induced apoptosis and transcription inhibition in tsHMG-expressing cells.

Main Results:

  • Mouse testicular cell extracts showed deficient repair of 1,2-d(GpG) cisplatin adducts but not 1,3-d(GpTpG) adducts.
  • Ectopic expression of tsHMG in HeLa cells modulated cisplatin-induced apoptosis.
  • tsHMG expression enhanced cisplatin-mediated transcription inhibition.

Conclusions:

  • HMG-domain proteins, specifically tsHMG, can influence cellular sensitivity to cisplatin.
  • Altered DNA repair mechanisms involving tsHMG may contribute to cisplatin efficacy in specific cancers.
  • These findings offer insights into tissue-specific responses to cisplatin chemotherapy.

More Related Videos

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.